Evidence map›Paper›PMID 29541345›Full record

ArticleOxidative medicine and cellular longevity2018

Corrigendum to "Protective Effects of Soy Oligopeptides in Ultraviolet B-Induced Acute Photodamage of Human Skin".

Bing-Rong Zhou, Li-Wen Ma, Juan Liu, Jia-An Zhang, Yang Xu, Di Wu, Felicia Permatasari, Dan Luo

Open access · hybridAbstract readPublished Erratum
In one paragraph

Article in Oxidative medicine and cellular longevity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. A Randomized Controlled Trial of the Genistein Plus Bakuchiol and Vitamins (GENSkin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2026
    Trial
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Bing-Rong ZhouDepartment of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.ORCID 0000-0002-7965-7624
Li-Wen MaDrum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
Juan LiuDepartment of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Jia-An ZhangDepartment of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Yang XuDepartment of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Di WuDepartment of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Felicia PermatasariDepartment of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.ORCID 0000-0002-6432-2637
Dan LuoDepartment of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.ORCID 0000-0001-6074-1298
Jiangsu Province Hospital · CNNanjing Drum Tower Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1155/2016/5846865.].

Identifiers

PMID29541345
PMCPMC5818946
OpenAlexW2783366279

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.